Main Session: Updates in Hodgkin Lymphoma

What should you be aware of when monitoring for toxicities linked with newer agents?

Sandra E. Kurtin
PhDc, ANP-C, AOCN
Arizona Cancer Center


Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me